More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$6.78B
EPS
18.89
P/E ratio
25.1
Price to sales
2.66
Dividend yield
0.502%
Beta
0.438804
Previous close
$475.41
Today's open
$475.50
Day's range
$473.51 - $480.66
52 week range
$408.42 - $623.61
show more
CEO
Kevin J. McNamara
Employees
15695
Headquarters
Cincinnati, OH
Exchange
New York Stock Exchange
Shares outstanding
14164195
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Chemed Stock Down 15% in a Year as One Fund Builds a $5.56 Million Stake
Barington Companies Management initiated a 13,000-share position in Chemed during the fourth quarter. The estimated trade value was $5.56 million.
The Motley Fool • Feb 16, 2026

Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents
CINCINNATI, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed's existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.
GlobeNewsWire • Feb 13, 2026

Chemed to Report Fourth-Quarter 2025 Earnings February 25, Related Conference Call to Be Held on February 26
CINCINNATI, Jan. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will release financial results for the fourth quarter ended December 31, 2025, on Wednesday, February 25, 2026, following the close of trading on the New York Stock Exchange.
GlobeNewsWire • Jan 2, 2026

Should Investors Hold Chemed Stock in Their Portfolio Now?
CHE shows growth momentum from VITAS and resilient Roto-Rooter results, but macro headwinds and competition continue to cloud its near-term outlook.
Zacks Investment Research • Dec 18, 2025

Chemed (CHE) Upgraded to Buy: Here's What You Should Know
Chemed (CHE) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks Investment Research • Dec 9, 2025

Chemed Corporation to Present at the BofA Securities 2025 Virtual Home Care Conference
CINCINNATI, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will present at the BofA Securities 2025 Virtual Home Care Conference on Tuesday, December 9, 2025, at 1:20 PM (ET). The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations).
GlobeNewsWire • Dec 4, 2025

Chemtrade Logistics Income Fund (CHE.UN:CA) Q3 2025 Earnings Call Transcript
Chemtrade Logistics Income Fund ( CHE.UN:CA ) Q3 2025 Earnings Call November 12, 2025 10:00 AM EST Company Participants Rohit Bhardwaj - VP of Finance & CFO Scott Rook - CEO, President & Trustee Conference Call Participants Nikolai Goroupitch Joel Jackson - BMO Capital Markets Equity Research Ben Isaacson - Scotiabank Global Banking and Markets, Research Division Presentation Operator Good morning, ladies and gentlemen, and welcome to Chemtrade Logistics Income Fund Third Quarter 2025 Conference Call. [Operator Instructions] I would now like to turn the conference call over to Rohit Bhardwaj, Chief Financial Officer.
Seeking Alpha • Nov 12, 2025

Chemed Corporation (CHE) Presents at UBS Global Healthcare Conference 2025 Transcript
Chemed Corporation ( CHE ) UBS Global Healthcare Conference 2025 November 11, 2025 2:00 PM EST Company Participants Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Kevin McNamara - CEO, President & Director Joel Wherley - CEO, President & Chief Operating Officer Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Presentation Albert Rice UBS Investment Bank, Research Division All right. Thanks, everyone.
Seeking Alpha • Nov 11, 2025

Wall Street Analysts Predict a 32.69% Upside in Chemed (CHE): Here's What You Should Know
The mean of analysts' price targets for Chemed (CHE) points to a 32.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks Investment Research • Nov 11, 2025

Chemed Corporation Declares Quarterly Dividend of 60 Cents
CINCINNATI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 60-cents per share on the Company's capital stock, payable on December 5, 2025, to shareholders of record as of November 17, 2025. This is equal to the dividend paid in August 2025. This represents the 218th consecutive quarterly dividend paid by Chemed in its 54 years as a public company.
GlobeNewsWire • Nov 7, 2025

¹ Disclosures

Open an M1 investment account to buy and sell Chemed Corp commission-free¹. Build wealth for the long term using automated trading and transfers.